Scope
This training program defines the complete knowledge and performance requirements for personnel involved in pharmaceutical manufacturing to become certified auditors for Current Good Manufacturing Practice (cGMP) in the United States regulatory environment. The program integrates FDA cGMP requirements from 21 CFR Part 210 (General Provisions) and 21 CFR Part 211 (Finished Pharmaceuticals) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor, CRO, and supplier audits) , and global regulatory compliance auditing.
The participant learns what FDA cGMP requires across all aspects of pharmaceutical manufacturing, how to audit those requirements, and how to conduct audits across multiple jurisdictions and organizational boundaries. ISO 19011:2026 provides the methodological framework for planning, conducting, reporting, and following up on audits. The standard covers audit principles , audit programme management , conducting management system audits , and evaluation of auditor competence.
Regulatory Frameworks Covered
- 21 CFR Part 210 establishes the General Provisions for cGMP in manufacturing, processing, packing, or holding of drugs. It sets the legal status of GMP, applies the regulations to different situations, and provides definitions for key terms used throughout all other parts.
- 21 CFR Part 211 contains the detailed requirements specifically for finished pharmaceuticals. This covers buildings and facilities, equipment, components and containers/closures, production and process controls, packaging and labeling, holding and distribution, laboratory controls, records and reports, and returned and salvaged drug products.
- Key Principles underlying all FDA cGMP requirements include: patient safety as the ultimate goal, prevention over detection, quality built in not tested in, documentation as evidence of compliance, following written procedures, and the independence of the Quality Control Unit.
- Legal Consequences of non-compliance include drug products being considered adulterated (even if they pass testing but were made under improper conditions), leading to seizure, injunction, and prosecution.
- Historical Foundations include the Elixir Sulfanilamide Disaster of 1937 (leading to the 1938 FD&C Act requiring safety) and the Thalidomide Tragedy of the 1960s (leading to the 1962 Kefauver-Harris Amendments requiring efficacy and mandating GMP).
- ISO 19011:2026 provides the Guidelines for auditing management systems , covering audit principles , audit programme management , conducting audits , remote auditing methods , and competence evaluation.
Auditing Practices Covered (ISO 19011:2026)
- Seven principles of auditing: integrity, fair presentation, due professional care, confidentiality, independence, evidence-based approach, and risk-based approach
- Audit programme management: objectives, risks, opportunities, resources, procedures, implementation, monitoring, review, and improvement
- Conduct of an audit: initiation, preparation, execution, reporting, and follow-up
- Remote and hybrid auditing methods: virtual audits, technology considerations, security, and contingency planning
- Competence and evaluation of auditors: personal behaviour, knowledge and skills, evaluation methods, and maintaining competence
- Second-party auditing: supplier qualification, vendor audits, and service provider oversight
Operational Areas Covered
- Quality Control Unit: independence, approval and rejection authority, production record review, procedure and specification approval, contract manufacturing oversight
- Personnel Qualifications: education, training, experience, supervision, and adequate staffing
- Personnel Responsibilities: clean clothing, protective apparel, sanitation, health habits, illness and lesion reporting
- Buildings and Facilities: design and construction, size and location, specific defined areas, aseptic processing requirements
- Equipment: design, size, location, construction materials, cleaning and maintenance, calibration
- Components and Containers/Closures: receipt, identification, storage, handling, sampling, testing, approval or rejection
- Production and Process Controls: written procedures, charge-in of components, yield calculation, equipment identification, in-process sampling and testing
- Packaging and Labeling: materials examination, labeling issuance, packaging operations, tamper-evident packaging
- Holding and Distribution: warehousing procedures, stock rotation, recall system
- Laboratory Controls: specifications, standards, sampling plans, test procedures, stability testing
- Records and Reports: production records, control records, distribution records, complaint files
- Returned and Salvaged Drug Products: identification, holding, evaluation, reprocessing, salvaging
The program is designed for global auditing across internal, second-party, and regulatory readiness contexts and does not qualify individuals to conduct regulatory inspections on behalf of authorities.
Objectives
Upon completion of this program, the participant will be able to:
- Interpret and apply FDA cGMP requirements from 21 CFR Part 210 and 21 CFR Part 211 to pharmaceutical manufacturing operations
- Understand and apply the seven auditing principles (integrity, fair presentation, due professional care, confidentiality, independence, evidence-based approach, and risk-based approach)
- Plan, manage, and execute internal, second-party, and global audits in full accordance with ISO 19011:2026
- Conduct supplier and vendor audits to assess compliance with FDA cGMP and contractual requirements
- Conduct facility audits to assess premises, equipment, and utility systems for cGMP compliance
- Develop audit checklists, sampling plans, and audit protocols tailored to pharmaceutical risks and regulatory requirements
- Collect objective evidence through on-site and remote interviews, observation, and document review
- Identify and classify non-conformities (critical, major, and minor) with clear justification referencing specific regulatory requirements
- Write non-conformity reports that are factual, complete, and actionable
- Prepare and distribute audit reports to appropriate management levels and stakeholders
- Notify management of critical findings using escalation procedures
- Track corrective and preventive actions using a formal tracking log with status codes
- Verify effectiveness of corrective and preventive actions
- Close an audit properly with closure memo and management acknowledgment
- Contribute audit results to management review and continual improvement
- Prepare organizations for FDA inspections and respond to inspection findings
Target Audience
This program is specifically designed for personnel involved in the manufacture, oversight, or auditing of pharmaceutical products in accordance with FDA cGMP requirements. Typical roles include:
- Quality Assurance Personnel – responsible for independent monitoring of pharmaceutical manufacturing, conducting internal and vendor audits, and assuring cGMP compliance across multiple regulatory frameworks
- Quality Control Personnel – responsible for laboratory operations, analytical testing, and stability programs; need to understand auditing principles and cGMP requirements for QC laboratories
- Production and Manufacturing Staff – responsible for manufacturing operations; need to understand how their processes will be audited and how to maintain cGMP compliance
- Engineering and Maintenance Personnel – responsible for equipment qualification, calibration, and facility maintenance; need to understand cGMP requirements for premises and equipment
- Warehouse and Logistics Staff – responsible for materials handling, storage, and distribution; need to understand cGMP requirements for warehouse operations
- Regulatory Affairs Professionals – responsible for regulatory submissions and compliance; need to understand cGMP requirements and auditing principles
- Supplier Qualification Professionals – responsible for supplier selection, qualification, and monitoring; need to understand auditing principles and supply chain cGMP requirements
- Contract Manufacturing Organization Personnel – service providers conducting manufacturing activities on behalf of sponsors; need to understand auditing requirements
- Microbiology and Sterility Assurance Personnel – responsible for environmental monitoring, sterility testing, and contamination control; need to understand auditing principles for sterile products
- Validation Personnel – responsible for process validation, cleaning validation, and equipment qualification; need to understand auditing requirements for validation activities
- Audit Program Managers – responsible for planning, managing, and overseeing audit programmes across multiple regions and vendors
- Regulatory Compliance Officers – responsible for ensuring organizational compliance with global cGMP regulations
Certification Requirements
To obtain the FDA cGMP Auditor Certification designation, the participant must complete the following steps:
- Complete all modules in sequence.
- Achieve a minimum score of 80 percent (8 out of 10 questions) on each module quiz.
Certificate of Completion
Upon successful completion of all module assessments and the final examination, you will receive a Certificate of Completion for the cGMP Auditor Certification Program (FDA-Focused).
Certificate Details:
- Participant’s full name and designation
- Training program title and date of completion
- Authorized signatory and issuing organization details
- Unique certificate number for verification purposes
